Kusajili – Clinical trials directory

Result of your search per sponsor: Jahlid Sehouli, MD

Woman Max 99 years
Jahlid Sehouli, MD Update Il y a 4 ans

Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer Primary evaluation of the safety, tolerability and feasibility regarding specific postoperative complications of an adjuvant treatment with catumaxomab administered after tumor resection.

Country Austria, Germany
organs None
Specialty None

Closed trial

More information